New hope for tough-to-treat lymphoma patients as trial tests promising drug cocktail
NCT ID NCT07159906
Summary
This study is testing a new combination of four drugs for adults with an aggressive type of blood cancer called diffuse large B-cell lymphoma, which has returned or not responded to standard treatments. The first part of the study will find the safest dose, and the second part will see how well the combination works to shrink tumors. Researchers hope this approach can help control the disease in patients who have few other options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, 310003, China
Conditions
Explore the condition pages connected to this study.